Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Marihuana and cannobinoids as medicaments].
Natalizumab adverse events are rare in patients with multiple sclerosis.
Self-reported Depression and Physical Activity in Adults with Mobility Impairments.
Treatment with natalizumab in relapsing-remitting multiple sclerosis patients induces changes in inflammatory mechanism.
Aging, widowhood, multiple sclerosis, and a dog.
NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis.
[Emerging therapies for multiple sclerosis.]
A hypermorphic SP1-binding CD24 variant associates with risk and progression of multiple sclerosis.
Visual evoked potentials in early diagnosis of demyelinating diseases - a case report of Devic's disease.
Motivational interviewing may improve exercise experience for people with multiple sclerosis: A small randomized trial.
MR Imaging in Multiple Sclerosis: The Accuracy of 3D Double Inversion Recovery at 3 Tesla and the Potential for Single Sequence Imaging.
Gut microbiome and the risk factors in central nervous system autoimmunity.
Low Dose Naltrexone for Treatment of Multiple Sclerosis: A Retrospective Chart Review of Safety and Tolerability.
ATP increases the migration of microglia across the brain endothelial cell monolayer.
25-Hydroxycholecalciferol status in plasma is linearly correlated to daily summer pasture time in cattle at 56°N.
Iranian family caregivers' challenges and issues in caring of multiple sclerosis patients: A descriptive explorative qualitative study.
Early detection of MS treatment complication may improve survival
Relationship between vitamin D and depression in multiple sclerosis.
T-bet or not T-bet: Taking the last bow on the autoimmunity stage.
A consensus statement addressing mesenchymal stem cell transplantation for multiple sclerosis: it's time!
[Oral disease modifying therapy of multiple sclerosis: the current view.]
Miscellaneous indications for extracorporeal photochemotherapy (ECP).
Post-Partum Treatment With Immunoglobulin Does Not Prevent Relapses of Multiple Sclerosis in the Mother.
Feedforward postural control in individuals with multiple sclerosis during load release.
Increasing age at disability milestones among MS patients in the MSBase Registry.
Pages
« first
‹ previous
…
227
228
229
230
231
232
233
234
235
…
next ›
last »